Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients

被引：13

作者：

Baron, Frederic ^{[1
,2
]}

Efficace, Fabio ^{[3
]}

Cannella, Laura ^{[3
]}

Willemze, Roel ^{[4
]}

Vignetti, Marco ^{[3
]}

Muus, Petra ^{[5
,6
]}

Marie, Jean-Pierre ^{[7
]}

Ferrero, Dario ^{[8
]}

Fazi, Paola ^{[3
]}

La Sala, Edoardo ^{[3
]}

Bourhis, Jean-Henri ^{[9
]}

Fabbiano, Francesco ^{[10
]}

Bosi, Alberto ^{[11
]}

Sborgia, Marco ^{[12
]}

Martinelli, Giovanni ^{[13
]}

Wittnebel, Sebastian ^{[14
]}

Trisolini, Silvia ^{[15
]}

Petti, Maria Concetta ^{[15
]}

Halkes, Constantijn J. M. ^{[4
]}

van der Velden, Walter J. F. M. ^{[5
]}

de Witte, Theo ^{[5
]}

Amadori, Sergio ^{[16
]}

Zittoun, Robert A. ^{[7
]}

Suciu, Stefan ^{[17
]}

机构：

[1] Univ Liege, GIGA I3, Liege, Belgium

[2] Univ Liege, CHU, Liege, Belgium

[3] Grp Italiano Malattie Ematol Adulto GIMEMA, Rome, Italy

[4] Leiden Univ, Med Ctr, Leiden, Netherlands

[5] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands

[6] Kings Coll Hosp London, London, England

[7] Hop Hotel Dieu, Paris, France

[8] Dept Med & Expt Oncol, Turin, Italy

[9] Gustave Roussy Canc Campus Grand Paris, Villejuif, France

[10] Osped Riuniti Villa Sofia Cervello, Palermo, Italy

[11] Univ Florence, Florence, Italy

[12] Osped Civile, Pescara, Italy

[13] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy

[14] Jules Bordet Inst, Brussels, Belgium

[15] Univ Roma La Sapienza, Rome, Italy

[16] Univ Tor Vergata, Rome, Italy

[17] EORTC Headquarters, Brussels, Belgium

来源：

HAEMATOLOGICA | 2020年 / 105卷 / 01期

关键词：

STEM-CELL TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; 1ST REMISSION; BLOOD; AML; ADULTS; RELAPSE;

D O I：

10.3324/haematol.2019.221333

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E13 / E16

页数：4

共 16 条

[11] High numbers of mobilized CD34+cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT [J].

Hengeveld, M. ;

Suciu, S. ;

Chelgoum, Y. ;

Marie, J-P ;

Muus, P. ;

Lefrere, F. ;

Mandelli, F. ;

Pane, F. ;

Amadori, S. ;

Fioritoni, G. ;

Labar, B. ;

Baron, F. ;

Cermak, J. ;

Bourhis, J-H ;

Storti, G. ;

Fazi, P. ;

Hagemeijer, A. ;

Vignetti, M. ;

Willemze, R. ;

de Witte, T. .

BONE MARROW TRANSPLANTATION, 2015, 50 (03) :341-347

[12] Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party [J].

Schuurhuis, Gerrit J. ;

Heuser, Michael ;

Freeman, Sylvie ;

Bene, Marie-Christine ;

Buccisano, Francesco ;

Cloos, Jacqueline ;

Grimwade, David ;

Haferlach, Torsten ;

Hills, Robert K. ;

Hourigan, Christopher S. ;

Jorgensen, Jeffrey L. ;

Kern, Wolfgang ;

Lacombe, Francis ;

Maurillo, Luca ;

Preudhomme, Claude ;

van der Reijden, Bert A. ;

Thiede, Christian ;

Venditti, Adriano ;

Vyas, Paresh ;

Wood, Brent L. ;

Walter, Roland B. ;

Doehner, Konstanze ;

Roboz, Gail J. ;

Ossenkoppele, Gert J. .

BLOOD, 2018, 131 (12) :1275-1291

[13] Autologous peripheral blood stem cell transplantation for acute myeloid leukemia [J].

Vellenga, Edo ;

van Putten, Wim ;

Ossenkoppele, Gert J. ;

Verdonck, Leo F. ;

Theobald, Matthias ;

Cornelissen, Jan J. ;

Huijgens, Peter C. ;

Maertens, Johan ;

Gratwohl, Alois ;

Schaafsma, Ron ;

Schanz, Urs ;

Graux, Carlos ;

Schouten, Harry C. ;

Ferrant, Augustin ;

Bargetzi, Mario ;

Fey, Martin F. ;

Lowenberg, Bob .

BLOOD, 2011, 118 (23) :6037-6042

[14] Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio [J].

Versluis, J. ;

't Hout, F. E. M. In ;

Devillier, R. ;

van Putten, W. L. J. ;

Manz, M. G. ;

Vekemans, M-C ;

Legdeur, M-C ;

Passweg, J. R. ;

Maertens, J. ;

Kuball, J. ;

Biemond, B. J. ;

Valk, P. J. M. ;

van der Reijden, B. A. ;

Meloni, G. ;

Schouten, H. C. ;

Vellenga, E. ;

Pabst, T. ;

Willemze, R. ;

Lowenberg, B. ;

Ossenkoppele, G. ;

Baron, F. ;

Huls, G. ;

Cornelissen, J. J. .

LEUKEMIA, 2017, 31 (01) :26-33

[15] Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation [J].

Wingard, John R. ;

Majhail, Navneet S. ;

Brazauskas, Ruta ;

Wang, Zhiwei ;

Sobocinski, Kathleen A. ;

Jacobsohn, David ;

Sorror, Mohamed L. ;

Horowitz, Mary M. ;

Bolwell, Brian ;

Rizzo, J. Douglas ;

Socie, Gerard .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (16) :2230-2239

[16] AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH INTENSIVE CHEMOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA [J].

ZITTOUN, RA ;

MANDELLI, F ;

WILLEMZE, R ;

DEWITTE, T ;

LABAR, B ;

RESEGOTTI, L ;

LEONI, F ;

DAMASIO, E ;

VISANI, G ;

PAPA, G ;

CARONIA, F ;

HAYAT, M ;

STRYCKMANS, P ;

ROTOLI, B ;

LEONI, P ;

PEETERMANS, ME ;

DARDENNE, M ;

VEGNA, ML ;

PETTI, MC ;

SOLBU, G ;

SUCIU, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :217-223

← 1 2 →